Context Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome
primarily caused by maternal opiate use. No national estimates are available for the …

Objective To examine opioid replacement therapy in pregnancy and effect on neonatal
outcomes, including length of hospital stay for neonatal abstinence syndrome. Design …

Background: Despite the high prevalence of psychiatric symptoms in substance-dependent
women, little evidence is available on postpartum depression in this population. Objectives …

Abstract The American Academy of Pediatrics (AAP) has a long-standing recommendation
against breastfeeding if the maternal methadone dose is above 20 mg/day. In 2001, the AAP …

In order to assess the long-term behavioral consequences of exposing rats to methadone
during gestation, lactation or both periods consecutively, pregnant Wistar dams were …

Drug Use and Health, conducted by the US Department of Health and Human Services, 1
found that 4.4% of pregnant women use illicit drugs, with a significantly higher rate of 16.2 …

Buprenorphine (BUP) is used for the maintenance of opioid‐addicted pregnant women.
Because BUP and its main metabolite nor‐BUP are excreted into breast milk, a sensitive …

OBJECTIVES: From a survey on the future of the mothers having been seen by the team of
coordination and intervention with the drug users (ECIMUD) of Mulhouse between 2004 and …

There is large variability in the dose of methadone required to prevent withdrawal symptoms
in chronic, stable methadone users. The difference in dose between low-dose and high …

The present paper considers naltrexone to treat opioid dependence during pregnancy. The
public health problem of opioid dependence and its treatment during pregnancy is reviewed …